SRX3207
目录号: PL09783 纯度: ≥98%
CAS No. :2254693-15-5
商品编号 规格 价格 会员价 是否有货 数量
PL09783-5mg 5mg ¥6429.00 请登录
PL09783-10mg 10mg ¥10929.00 请登录
PL09783-25mg 25mg ¥21698.00 请登录
PL09783-50mg 50mg ¥35360.00 请登录
PL09783-100mg 100mg ¥54647.00 请登录
PL09783-200mg 200mg 询价 询价
PL09783-500mg 500mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
SRX3207
英文名称
SRX3207
英文别名
SRX3207;s8948;3-[4-[[4-[4-(Azetidin-1-ylmethyl)-3-methylpyrazol-1-yl]pyrimidin-2-yl]amino]phenyl]-5-morpholin-4-yl;3-(4-((4-(4-(Azetidin-1-ylmethyl)-3-methyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)phenyl)-5-morpholino-7H-thieno[3,2-b]pyran-7-one;3-[4-[[4-[4-(Azetidin-1-ylmethyl)-3-methylpyrazol-1-yl]pyrimidin-2-yl]amino]phenyl]-5-morpholin-4-yl
Cas No.
2254693-15-5
分子式
C29H29N7O3S
分子量
555.65
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
SRX3207 是具有口服活性的、首创的 Syk/PI3K 双抑制剂,其对 Syk 和 PI3Kα 的 IC50 值分别为 10.7 nM 和 861 nM。SRX3207 缓解抗肿瘤免疫抑制。
生物活性
SRX3207 is an orally active and first-in-class dual Syk/PI3K inhibitor, with IC 50 values of 10.7 nM and 861 nM for Syk and PI3Kα, respectively. SRX3207 relieves tumor immunosuppression.
性状
Solid
IC50 & Target[1][2]
Syk 10.7 nM (IC50) PI3Kα 861 nM (IC50
体外研究(In Vitro)
SRX3207 (10 μmol/L) is able to block p-AKT at concentration.
SRX3207 has sufficient solubility in water (43 μmol/L). has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
SRX3207 (10 mg/kg, orally) increases antitumor immune response. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: LLC or B16 or B16-OVA or CT26 (1 × 10) cells were injected subcutaneous
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Shweta Joshi, et al. Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression. Molecular Cancer Therapeutics. 2020.
[2]. Shweta Joshi, et al. Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression. Mol Cancer Ther. 2020 Mar;19(3):755-764.
溶解度数据
In Vitro: DMSO : 5 mg/mL (9.00 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2